Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience (Q42082355)

16 October 2017

title

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience (English)

1 reference

acute myocardial infarction

16 October 2017

main subject

myocardial infarction

1 reference

1 reference

1 reference

D A Rothbaum

1

1 reference

16 October 2017

T J Linnemeier

2

1 reference

16 October 2017

R J Landin

3

1 reference

16 October 2017

E F Steinmetz

4

1 reference

16 October 2017

J S Hillis

5

1 reference

16 October 2017

C C Hallam

6

1 reference

16 October 2017

R J Noble

7

1 reference

16 October 2017

M R See

8

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 August 1987

1 reference

Journal of the American College of Cardiology

16 October 2017

published in

1 reference

16 October 2017

volume

10

1 reference

16 October 2017

issue

2

1 reference

16 October 2017

page(s)

264-272

1 reference

Thrombolytic therapy in patients with acute myocardial infarction.

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Intravenous urokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Late effects of intracoronary streptokinase on regional wall motion, ventricular aneurysm and left ventricular thrombus in myocardial infarction: results from the Western Washington Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Necropsy evaluation in seven patients with evolving acute myocardial infarction treated with thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

The use of single plane angiocardiograms for the calculation of left ventricular volume in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Relation between the transmural extent of acute myocardial infarction and associated myocardial contractility two weeks after infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980006-2

7 January 2021

10.1016/S0735-1097(87)80006-2

Identifiers

DOI

1 reference

16 October 2017

1 reference